Osteoarthritis Ankle Clinical Trial
Official title:
A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate (MONOVISC) to Provide Symptomatic Relief of Osteoarthritis of Ankle Joint
The goal of this study is to demonstrate the clinical improvement and safety in patients treated with MONOVISC for ankle osteoarthritis. Specifically, this study will provide confirmation to the effectiveness and safety of MONOVISC at relieving ankle joint pain to 6 months post-treatment.
Obtain real world, post market data to confirm the clinical improvement and safety in patients treated with a single injection of MONOVISC for the symptomatic relief of osteoarthritis in the ankle joint. The entire study duration from first subject in to last subject out will be approximately one and half years. The enrollment phase will be approximately 12 months with a follow-up phase of 6 months. Visits will be scheduled at screening, baseline, 1 month, 3 months and 6 months post treatment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03711773 -
Outcomes of Low-Impact Exercise Program for People With Ankle, Knee, and/or Hip Pain
|
N/A | |
| Completed |
NCT05275244 -
Evaluate Clinical Benefit of Local Treatment With KD Intra-Articular® Gel in Patients With Osteoarthritis (NO-DOLOR2)
|
||
| Recruiting |
NCT05912153 -
SPECT-CT vs MRI for the Diagnosis of Osteoarthritis in the Foot and Ankle
|
||
| Completed |
NCT04562896 -
Iterative Design of Custom Dynamic Orthoses to Reduce Articular Contact Stress
|
N/A | |
| Recruiting |
NCT04770870 -
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
|
N/A | |
| Withdrawn |
NCT05209347 -
Custom Dynamic Orthoses to Reduce Articular Contact Stress
|
N/A |